The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic…

Overview of attention for article published in Journal of the American Academy of Dermatology, April 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 41 news outlets
blogs: 2 blogs
policy: 1 policy source

twitter: 7 X users
patent: 17 patents
guideline: 2 clinical guideline sources

Readers on

mendeley: 155 Mendeley

So far, Altmetric has seen 10 X posts from 7 X users, with an upper bound of 97,177 followers.

Desarrollan un nuevo instrumento de medición de resultados clínicos para la gravedad de la #DermatitisAtópica: Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD). https://t.co/vM929ksdVm https://t.co/v8VnUYthZt

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis https://t.co/7c9UMijrOK https://t.co/0gDcn59dso

RT @TodoDermatitis: Desarrollan un nuevo instrumento de medición de resultados clínicos para la gravedad de la #DermatitisAtópica: Validate…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 6 additional X posts.